| Year |
Citation |
Score |
| 2008 |
Erickson RI, Paucar AA, Jackson RL, Visnyei K, Kornblum H. Roles of insulin and transferrin in neural progenitor survival and proliferation. Journal of Neuroscience Research. 86: 1884-94. PMID 18293414 DOI: 10.1002/Jnr.21631 |
0.58 |
|
| 2006 |
Groszer M, Erickson R, Scripture-Adams DD, Dougherty JD, Le Belle J, Zack JA, Geschwind DH, Liu X, Kornblum HI, Wu H. PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proceedings of the National Academy of Sciences of the United States of America. 103: 111-6. PMID 16373498 DOI: 10.1073/Pnas.0509939103 |
0.377 |
|
| 2006 |
Visnyei K, Tatsukawa KJ, Erickson RI, Simonian S, Oknaian N, Carmichael ST, Kornblum HI. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion. Experimental Neurology. 197: 465-74. PMID 16310773 DOI: 10.1016/J.Expneurol.2005.10.023 |
0.551 |
|
| 2001 |
Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A, Zack JA, Kornblum HI, Liu X, Wu H. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science (New York, N.Y.). 294: 2186-9. PMID 11691952 DOI: 10.1126/Science.1065518 |
0.727 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Crawford JJ, Johnson AR, Misner DL, Belmont LD, Castanedo GM, Choy R, Coraggio M, Dong L, Eigenbrot C, Erickson R, Ghilardi N, Hau J, Katewa A, Kohli PB, Lee W, et al. Discovery of GDC-0853, a Potent, Selective, and Non-Covalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development. Journal of Medicinal Chemistry. PMID 29457982 DOI: 10.1021/Acs.Jmedchem.7B01712 |
0.191 |
|
| 2016 |
Erickson RI, Schutt LK, Tarrant J, McDowell M, Liu L, Johnson AR, Lewin-Koh SC, Hedehus M, Ross J, Carano RA, Staflin K, Zhong F, Crawford J, Zhong S, Reif K, et al. BTK small molecule inhibitors induce a distinct pancreatic toxicity in rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 27821712 DOI: 10.1124/Jpet.116.236224 |
0.161 |
|
| 2022 |
Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, et al. Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients. Clinical and Translational Science. PMID 35649245 DOI: 10.1111/cts.13317 |
0.151 |
|
| 2013 |
Erickson RI, Tarrant J, Cain G, Lewin-Koh SC, Dybdal N, Wong H, Blackwood E, West K, Steigerwalt R, Mamounas M, Flygare JA, Amemiya K, Dambach D, Fairbrother WJ, Diaz D. Toxicity profile of small-molecule IAP antagonist GDC-0152 is linked to TNF-α pharmacology. Toxicological Sciences : An Official Journal of the Society of Toxicology. 131: 247-58. PMID 22956632 DOI: 10.1093/Toxsci/Kfs265 |
0.141 |
|
| 2019 |
Grievink HW, Heuberger JAAC, Huang F, Chaudhary R, Birkhoff WAJ, Tonn GR, Mosesova S, Erickson R, Moerland M, Haddick PCG, Scearce-Levie K, Ho C, Groeneveld GJ. DNL104, a centrally penetrant RIPK1 inhibitor, inhibits RIP1 kinase phosphorylation in a randomized phase I ascending dose study in healthy volunteers. Clinical Pharmacology and Therapeutics. PMID 31437302 DOI: 10.1002/cpt.1615 |
0.127 |
|
| 2011 |
Erickson RI, Defensor EB, Fairchild DG, Mirsalis JC, Steinmetz KL. Neurological assessments after treatment with the antimalarial β-arteether in neonatal and adult rats. Neurotoxicology. 32: 432-40. PMID 21477617 DOI: 10.1016/j.neuro.2011.03.003 |
0.115 |
|
| 2011 |
Erickson RI, Defensor EB, Fairchild DG, Mirsalis JC, Steinmetz KL. WITHDRAWN. Neurological assessments after treatment with the antimalarial β-arteether in neonatal and adult rats. Neurotoxicology. 32: 423-31. PMID 21376079 DOI: 10.1016/j.neuro.2011.02.005 |
0.115 |
|
| 2017 |
Patel S, Meilandt WJ, Erickson RI, Chen J, Deshmukh G, Estrada AA, Fuji RN, Gibbons P, Gustafson A, Harris SF, Imperio J, Liu W, Liu X, Liu Y, Lyssikatos JP, et al. Selective Inhibitors of Dual Leucine Zipper Kinase (DLK, MAP3K12) with Activity in a Model of Alzheimer's Disease. Journal of Medicinal Chemistry. PMID 28929759 DOI: 10.1021/Acs.Jmedchem.7B00843 |
0.113 |
|
| 2013 |
Wong H, Gould SE, Budha N, Darbonne WC, Kadel EE, La H, Alicke B, Halladay JS, Erickson R, Portera C, Tolcher AW, Infante JR, Mamounas M, Flygare JA, Hop CE, et al. Learning and confirming with preclinical studies: modeling and simulation in the discovery of GDC-0917, an inhibitor of apoptosis proteins antagonist. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 2104-13. PMID 24041744 DOI: 10.1124/Dmd.113.053926 |
0.078 |
|
| 2012 |
Wong H, Budha NR, West K, Blackwood E, Ware JA, Yu R, Darbonne WC, Gould SE, Steigerwalt R, Erickson R, Hop CE, LoRusso P, Eckhardt SG, Wagner A, Chan IT, et al. Dogs are more sensitive to antagonists of inhibitor of apoptosis proteins than rats and humans: a translational toxicokinetic/toxicodynamic analysis. Toxicological Sciences : An Official Journal of the Society of Toxicology. 130: 205-13. PMID 22843607 DOI: 10.1093/Toxsci/Kfs235 |
0.075 |
|
| 2017 |
Bantseev V, Erickson R, Leipold D, Amaya C, Miller PE, Booler H, Thackaberry EA. Nonclinical Safety Assessment of Anti-Factor D: Key Strategies and Challenges for the Nonclinical Development of Intravitreal Biologics. Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association For Ocular Pharmacology and Therapeutics. PMID 29148965 DOI: 10.1089/jop.2017.0063 |
0.052 |
|
| 1960 |
ERICKSON RI, WAITE DE, WILKISON RH. A study of dry sockets. Oral Surgery, Oral Medicine, and Oral Pathology. 13: 1046-50. PMID 13820603 |
0.034 |
|
| 2011 |
Erickson R, Defensor E, Fairchild D, Mirsalis J, Steinmetz K. Erratum to “Neurological assessments after treatment with the antimalarial β-arteether in neonatal and adult rats” [Neurotoxicology 32 (2011) 423-431] Neurotoxicology. 32: 989. DOI: 10.1016/j.neuro.2011.06.001 |
0.026 |
|
| 1962 |
Erickson RI, Hale ML. Minor salivary gland sialolithiasis. Report of a case Oral Surgery, Oral Medicine, Oral Pathology. 15: 200-202. |
0.02 |
|
| 1982 |
Erickson RI. The elderly patient: a new challenge for dentists. Cda Journal California Dental Association. 10: 49-50. PMID 6957271 |
0.017 |
|
| 1961 |
ERICKSON RI, HALE ML. An effective and simplified method for cardiac resuscitation. Journal of Oral Surgery, Anesthesia, and Hospital Dental Service. 19: 322-5. PMID 13697124 |
0.016 |
|
| 2013 |
Xu K, Liu L, Dere R, Mai E, Erickson R, Hendricks A, Lin K, Junutula JR, Kaur S. Characterization of the drug-to-antibody ratio distribution for antibody-drug conjugates in plasma/serum. Bioanalysis. 5: 1057-71. PMID 23641696 DOI: 10.4155/bio.13.66 |
0.01 |
|
| 2013 |
Barkmeier WW, Erickson RI, Latta MA, Wilwerding TM. Wear rates of resin composites. Operative Dentistry. 38: 226-33. PMID 22856679 DOI: 10.2341/12-112-L |
0.01 |
|
| 2012 |
Erickson RI, Karduna AR. Three-dimensional repositioning tasks show differences in joint position sense between active and passive shoulder motion. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 30: 787-92. PMID 22072560 DOI: 10.1002/jor.22007 |
0.01 |
|
| 2003 |
Kuwata KT, Erickson RI, Doyle JR. A comparative study of interatomic potentials for copper and aluminum gas phase sputter atom transport simulations Nuclear Instruments and Methods in Physics Research, Section B: Beam Interactions With Materials and Atoms. 201: 566-570. DOI: 10.1016/S0168-583X(02)02230-9 |
0.01 |
|
| 1964 |
ERICKSON RI. ULTRASOUND--A USEFUL ADJUNCT IN TEMPOROMANDIBULAR JOINT THERAPY. Oral Surgery, Oral Medicine, and Oral Pathology. 18: 176-9. PMID 14176601 |
0.01 |
|
| 1962 |
ERICKSON RI, HALE ML. Minor salivary glad sialolithiasis. Report of a case. Oral Surgery, Oral Medicine, and Oral Pathology. 15: 200-2. PMID 13890557 |
0.01 |
|
| Hide low-probability matches. |